Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are recruited into the tumor site to fight against tumors. However, their small number and reduced activity limit their ability to overcome the tumor. Enhancement of TILs number and activity against tumors has b...
Main Authors: | Mohammad Hossein Kazemi, Maryam Sadri, Alireza Najafi, Ali Rahimi, Zeinab Baghernejadan, Hossein Khorramdelazad, Reza Falak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1018962/full |
Similar Items
-
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
by: Mahshid Panahi, et al.
Published: (2023-01-01) -
Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma
by: Zhongling Sun, et al.
Published: (2024-04-01) -
Advances and prospects in tumor infiltrating lymphocyte therapy
by: Xu Qiu, et al.
Published: (2024-11-01) -
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products
by: Suzanne M. Castenmiller, et al.
Published: (2024-12-01) -
Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
by: Yajing Zhu, et al.
Published: (2022-11-01)